BRIEF published on 10/24/2024 at 22:10, 27 days 15 hours ago Jumia to Announce Q3 2024 Results on November 7 Conference Call Earnings Report Investor Relations Jumia Q3 2024 Results
PRESS RELEASE published on 10/24/2024 at 22:05, 27 days 15 hours ago Jumia to Announce Third Quarter 2024 Results on November 7, 2024 Jumia Technologies AG to release Q3 2024 results on November 7, 2024. Conference call at 8:30am ET. Details for call and webcast available. About Jumia's e-commerce platform Conference Call E-commerce Platform Jumia Technologies AG JumiaPay Q3 2024 Results
BRIEF published on 10/16/2024 at 11:05, 1 month 5 days ago Jumia to Exit South Africa and Tunisia to Focus on Growth Markets Growth Strategy South Africa Jumia Tunisia Market Exit
PRESS RELEASE published on 10/16/2024 at 11:00, 1 month 5 days ago Jumia To Cease Operations in Non-Strategic Markets Jumia Technologies AG to optimize resources by closing operations in South Africa and Tunisia. Focus on high-growth markets for better efficiency and growth acceleration E-commerce Jumia Technologies AG South Africa Tunisia Operations Closure
BRIEF published on 10/10/2024 at 22:10, 1 month 10 days ago Jumia Expands Warehouse Operations in Egypt and Ivory Coast Expansion Jumia Warehouses Africa E-commerce Egypt Ivory Coast
PRESS RELEASE published on 10/10/2024 at 22:05, 1 month 10 days ago Jumia Announces New Integrated Warehouses in Egypt and Ivory Coast Jumia expands warehouse capacity in Egypt and Ivory Coast to boost e-commerce growth and efficiency, in line with pan-African strategy Efficiency Africa E-commerce Growth Jumia Warehouse Expansion
BRIEF published on 08/16/2024 at 15:08, 3 months 4 days ago Jumia Completes At-the-Market Offering, Raising $99.6 Million Growth Strategy Jumia ATM Offering Capital Raised E-commerce Africa
PRESS RELEASE published on 08/16/2024 at 15:03, 3 months 4 days ago Jumia Announces Completion of At-the-Market Offering Jumia Technologies AG strengthens balance sheet with $99.6 million in gross proceeds from successful equity offering. Funds to support growth initiatives Profitability Equity Offering Jumia Technologies AG Balance Sheet Growth Initiatives
BRIEF published on 08/06/2024 at 13:05, 3 months 15 days ago Jumia Reports Resilient Second Quarter 2024 Results EBITDA Financial Performance Revenue Jumia Q2 2024 Results
PRESS RELEASE published on 08/06/2024 at 13:00, 3 months 15 days ago Jumia Reports Second Quarter 2024 Results Jumia Technologies AG reports Q2 2024 financial results with revenue at $36.5M, GMV at $170.1M, and operating loss of $20.2M. Strategic priorities boost usage and cash efficiency Financial Results Revenue Jumia Technologies AG Q2 2024 Operating Loss
Published on 11/21/2024 at 13:30, 15 minutes ago AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 13:30, 15 minutes ago Datametrex Secures Additional P.O. Approx $250K for IT Services
Published on 11/21/2024 at 13:00, 45 minutes ago Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 45 minutes ago Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 45 minutes ago Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
Published on 11/21/2024 at 12:35, 1 hour 10 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 30 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 06:58, 6 hours 47 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 25 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
